5Wernick M H, Jeremias A, Carrozza J P. Drug-eluting stents and stent thrombosis: a cause for concern? [J]. Coron Ar- tery Dis, 2006,17(8) :661-665.
6Grines C L, Bonow R O, Casey D E Jr, et al. Prevention of premature discontinuation of dual antiplatelet therapy in pa- tients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiolo- gy, Society for Cardiovascular Angiography and Interven- tions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians[J]. Circulation, 2007,115(6) :813-818.
7Ong A T, Hoye A, Aoki J,et al. Thirty-day incidence and sixmonth clinical outcome of thrombotic stent occlusion after bare-metal,sirolimus, or paclitaxel stent implantation [ J ]. J Am Coll Cardiol,2005,45 (6) :947-953.
8Stone G W,Peterson M A,Lansky A J,et al.Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction[J].J Am Coll Cardiol,2002,39(4):591-597.
9Saito S,Hosokawa G,Tanaka S,et al.Primary stent implantation is superior to balloon angioplasty in acute myocardial infarction:final results of the primary angioplasty versus stent implantation in acute myocardial infarction (PASTA) trial.PASTA Trial Investigators[J].Catheter Cardiovasc Interv,1999,48(3):262-268.
10Eeckhout E,Kern M J.The coronary no-reflow phenomenon:a review of mechanisms and therapies[J].Eur Heart J,2001,22(9):729-739.
5Armstrong E J, Feldman D N, Wang T Y, et al. Clinical presentation, management, and outcomes of angiographi- cally documented early, late, and very late stent thrombo- sis [ J ]. JACC Cardiovasc Interv, 2012,5 ( 2 ) : l 31-140.
6Brodie B R, Hansen C, Garberich R F, et al. ST-seg- ment elevation myocardial infarction resulting from stent thrombosis: an enlarging subgroup of high-risk patients [J]. J Am Coil Cardiol, 2012,60(19) :1989-1991.
7Stone G W, Moses J W, Ellis S G, et al. Safety and effi- cacy of sirolimus and paclitaxel-eluting coronary stents [J]. N Engl J Med, 2007,356(10) :998-1008.
8Cutlip D E, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials: a case for standardized def- initions[J]. Circulation, 2007,115 ( 17 ) :2344-2351.
9Palmerini T, Kirtane A J, Serruys P W, et al. Stent thrombosis with everolimus-eluting stents: meta-analysis of comparative randomized controlled trials [J]. Circ Car- diovasc Interv, 2012,5 ( 3 ) :357-364.
10Sarno G, Lagerqvist B, Frobert O, et al. Lower risk of stent thrombosis and restenosis with unrestricted use of j new-generation'drug-eluting stents: a report from the na- tionwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR) [ J ]. Eur Heart J, 2012,33 ( 5 ) :606- 613.
